SelSym Biotech
PrivateLast Round
Seed
Apr 16, 2024
Total Funding Raised
$4.73M
Company Overview
SelSym Biotech is a biotechnology company developing synthetic platelet technologies to control bleeding in trauma and surgery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices, Defense Tech
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SelSym Biotech Comps
Public and private peers based on sector, stage, and business model.
SelSym Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 16, 2024 | ||||
| Grant | Apr 1, 2024 | ||||
| Grant | Sep 1, 2022 | ||||
| Grant | Sep 15, 2021 |
SelSym Biotech Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2025
Grew 50% QoQ from 6 to 9 employees.
- Apr 16, 2024
$5M round completed.
SelSym Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SelSym Biotech's valuation, stock price, and market status.
